This is not the most recent version of the article. View current version (22 NOV 2016)

Intervention Protocol

You have free access to this content

Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care

  1. Greg Weeks1,*,
  2. Johnson George1,
  3. Katie Maclure2,
  4. Derek Stewart2

Editorial Group: Cochrane Effective Practice and Organisation of Care Group

Published Online: 22 JUL 2014

Assessed as up-to-date: 21 JUL 2014

DOI: 10.1002/14651858.CD011227


How to Cite

Weeks G, George J, Maclure K, Stewart D. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD011227. DOI: 10.1002/14651858.CD011227.

Author Information

  1. 1

    Monash University, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Parkville, VIC, Australia

  2. 2

    Robert Gordon University, School of Pharmacy, Aberdeen, UK

*Greg Weeks, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Pde, Parkville, VIC, 3052, Australia. greg@barwonhealth.org.au. gregory.weeks@monash.edu.

Publication History

  1. Publication Status: New
  2. Published Online: 22 JUL 2014

SEARCH

This is not the most recent version of the article. View current version (22 NOV 2016)

References

Additional references

Australian National Health Workforce 2010
  • Australian National Health Workforce, Planning & Research Collaboration. Non-medical prescribing: an exploration of likely nature of, and contingencies for developing a nationally consistent approach to prescribing for non-medical health professionals. June 2010. http://www.ahwo.gov.au/documents/NHWT/Non%20Medical%20Prescribing%20Final%20Report.pdf (accessed 3 November 2012).
Benney 2000
  • Beney J, Bero LA, Bond CM. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes . Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD000336]
Bhanbhro 2011
  • Bhanbhro S, Drennan VM, Grant R, Harrios R. Assessing the contribution of prescribing in primary care by nurses and professionals allied to medicine: a systematic review of literature. BMC Health Services Research 2011;11:330.
Bissell 2008
  • Bissell P, Cooper R, Guillaume L, Anderson C, Avery A, Hutchinson A, et al. An evaluation of supplementary prescribing in nursing and pharmacy. Final report for the Department of Health. Research Report. University of Sheffield. October 2008. www.sheffield.ac.uk/content/1/c6/09/11/83/Supplementary_prescribing.pdf (accessed 3 November 2012).
Cochrane EPOC Group 2002
  • Cochrane Effective Practice and Organisation of Care Review Group. Data Collection Checklist. June 2002. Available from http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf.
Cochrane EPOC Group 2013a
  • Cochrane Effective Practice and Organisation of Care Group. Effective Practice and Organisation of Care (EPOC). EPOC Resources for review authors. Data extraction and management. Oslo: Norwegian Knowledge Centre for the Health Services; 2013. Available at: http://epocoslo.cochrane.org/epoc-specific-resources-review-authors.
Cochrane EPOC Group 2013b
  • Cochrane Effective Practice and Organisation of Care Group. Effective Practice and Organisation of Care (EPOC). EPOC Resources for review authors. Suggested risk of bias criteria for EPOC reviews. Oslo: Norwegian Knowledge Centre for the Health Services; 2013. Available at: http://epocoslo.cochrane.org/epoc-specific-resources-review-authors.
Cooper 2008
  • Cooper R, Guillaume L, Avery T, Anderson C, Bissell P, Hutchinson A, et al. Nonmedical prescribing in the United Kingdom Development and stakeholder Interests. Journal of Ambulatory Care Management 2008;31(3):244-52.
Department of Health 1999
  • Department of Health. Review of prescribing, supply and administration of medicines (the Crown Report). March 1999. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyandGuidance/DH_4077151 (accessed 3 November 2012).
Department of Health 2003
  • Department of Health. Supplementary prescribing by nurses and pharmacists within the NHS in England. A guide for implementation. February 2003. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4009717 (accessed 3 November 2012).
Department of Health 2006
  • Department of Health. Improving patients' access to medicines: A guide to implementing nurse and pharmacist independent prescribing within the NHS in England. April 2006. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/PublicationsandStatistics/Publications/PublicationsPolicyandGuidance/DH_4133743 (accessed 3 November 2012).
Duckett 2005
  • Duckett S. Health workforce design for the 21st century. Australian Health Review 2005;29(2):201-10.
Ellis 2006
Hawkins 1979
  • Hawkins D, Fiedler FP, Douglas HL, Eschbach RC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. American Journal of Hospital Pharmacy 1979;36(10):1321-5.
Health Workforce Australia 2013
  • Health Workforce Australia 2013. Health Professionals Prescribing Pathway (HPPP) Project - Final Report. http://www.hwa.gov.au/sites/uploads/HPPP-Final-Report-November-2013.pdf (a ccessed 12 February 2014).
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Home Office 2012
  • Home Office. Circular: nurse and provisions pharmacist independent prescribing for Schedule 4 Part II drugs. Home Office circular 009/2012. https://www.gov.uk/government/publications/nurse-and-pharmacist-independent-prescribing-mixing-of-medicines-possession-authorities-under-patient-group-directions-and-personal-exemption-provisions-for-schedule-4-part-ii-drugs (accessed 12 January 2013).
Hooker 2006
Kay 2004
Latter 2010
  • Latter S, Blenkinsopp A, Smith A, Chapman S, Tinelli M, Gerard K, et al. Evaluation of nurse and pharmacist independent prescribing. Department of Health Policy Research Programme Project 016 0108. University of Southampton; Keele University, on behalf of Department of Health. October 2010. http://eprints.soton.ac.uk/184777/ (accessed 3 November 2012).
Laurant 2004
Law 2012
  • Law M, Ma T, Fisher J, Sketris I. Independent pharmacist prescribing in Canada. Canadian Pharmacists Journal 2012;145(1):17-23.
Law 2013
  • Law AV, Gupta EK, Hess KM, Klotz RS, Le QA, Schwartzman E, et al. Collaborative pharmacy practice: an update. Integrated Pharmacy Research Practice 2013;2:1-16.
National Prescribing Centre 2012
  • National Prescribing Centre, National Institute for Health and Clinical Excellence. A single competency framework for all prescribers. May 2012. http://www.npc.co.uk/improving_safety/improving_quality/resources/single_comp_framework_v2.pdf (accessed 21 June 2012).
National Prescribing Service 2012
  • National Prescribing Service MedicineWise. NPS: Better choices, Better health. Competencies required to prescribe medicines: putting quality use of medicines into practice. Sydney: National Prescribing Service Limited, 2012. http://www.nps.org.au/__data/assets/pdf_file/0004/149719/Prescribing_Competencies_Framework.pdf (accessed 12 December 2012).
Pharmacy Council of New Zealand 2013
  • Pharmacy Council of New Zealand. Pharmacist Prescribers. 2013. http://www.pharmacycouncil.org.nz/cms_display.php?sn=225&st=1&pg=1863 (accessed 26 December 2013).
Phillips 2008
Ramsay 2003
  • Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE. Interrupted time series design in health technology assessment: Lessons from two systematic reviews of behaviour change strategies. International Journal of Technology Assessment in Health Care 2003;19(4):612-23.
Review Manager 2014 [Computer program]
  • The Nordic Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Centre, The Cochrane Collaboration, 2014.
Stewart 2010
  • Stewart D, Cunningham S, Diack L, McCaig D, MacLure K, Bond C, et al. Prescribing Research Group, NHS Education for Scotland. Report: Exploring and evaluating pharmacist prescribing. June 2010. Available from https://www4.rgu.ac.uk/files/RGU%20Prescribing%20Research%20Group%20Report.pdf (accessed 12 Jan 2013).
Thomas 2006
  • Thomas J, Murtuza B, Lin Shu-Wen, Yogesh P. Survey of pharmacist collaborative drug therapy management in hospitals. American Journal of Health-System Pharmacy 2006;63:2489-99.
Tonna 2007
Weeks 2008
Wheeler 2012
  • Wheeler A, Crump K, Lee M, Li L, Patel A, Yang R, et al. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health. Research in Social and Administrative Pharmacy 2012;8(3):179-92.
WHO 2012
  • World Health Organization. World Health Statistics 2012. www.who.int/gho/publications/world_health_statistics/EN_WHS2012_Full.pdf. France, (accessed 10 Feb 2013).
Yuksel 2008